HK Stock MarketDetailed Quotes

01244 3D MEDICINES

Watchlist
  • 1.680
  • +0.010+0.60%
Market Closed Nov 29 16:08 CST
433.79MMarket Cap-880P/E (TTM)

3D MEDICINES Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Turnover
-41.45%206.42M
11.91%634.95M
--352.55M
841.57%567.39M
--60.26M
----
----
Operating income
-41.45%206.42M
11.91%634.95M
352.55M
841.57%567.39M
60.26M
Cost of sales
36.00%-17.47M
-16.29%-49.09M
---27.3M
-887.02%-42.22M
---4.28M
----
----
Operating expenses
36.00%-17.47M
-16.29%-49.09M
-27.3M
-887.02%-42.22M
-4.28M
Gross profit
-41.91%188.95M
11.55%585.86M
325.25M
838.10%525.18M
55.98M
Selling expenses
50.18%-110.08M
-5.91%-378.81M
---220.97M
-734.99%-357.66M
---42.83M
----
----
Administrative expenses
44.49%-43.5M
-51.98%-217.08M
---78.37M
5.38%-142.83M
-272.47%-150.96M
1.37%-40.53M
---41.09M
Research and development expenses
43.74%-85.29M
-21.27%-425.5M
---151.61M
5.47%-350.86M
-40.61%-371.16M
-15.07%-263.97M
---229.39M
Revaluation surplus
----
----
----
31.17%-657.16M
-199.07%-954.74M
-23,830.43%-319.23M
---1.33M
-Changes in the fair value of other assets
----
----
----
31.17%-657.16M
-199.07%-954.74M
-23,830.43%-319.23M
---1.33M
Impairment and provision
-1,622.38%-4.77M
171.23%837K
---277K
-803.85%-1.18M
---130K
----
----
-Other impairment is provision
-1,622.38%-4.77M
171.23%837K
---277K
-803.85%-1.18M
---130K
----
----
Special items of operating profit
9.77%-54.32M
-86.31%-120.01M
---60.19M
-1,917.47%-64.41M
198.66%3.54M
89.25%-3.59M
---33.41M
Operating profit
41.44%-109.01M
47.12%-554.69M
-186.16M
28.17%-1.05B
-132.78%-1.46B
-105.53%-627.32M
-305.23M
Financing cost
-25.23%-5.06M
-149.66%-7.77M
---4.04M
-103.73%-3.11M
81.04%-1.53M
47.01%-8.06M
---15.21M
Earning before tax
40.03%-114.07M
46.54%-562.47M
-190.2M
28.03%-1.05B
-130.07%-1.46B
-98.29%-635.38M
-320.43M
Tax
----
---55K
----
----
----
----
----
After-tax profit from continuing operations
40.03%-114.07M
46.53%-562.52M
-190.2M
28.03%-1.05B
-130.07%-1.46B
-98.29%-635.38M
-320.43M
Earning after tax
40.03%-114.07M
46.53%-562.52M
-190.2M
28.03%-1.05B
-130.07%-1.46B
-98.29%-635.38M
-320.43M
Minority profit
9.85%-10.57M
-36.65%-37.82M
---11.72M
0.19%-27.68M
---27.73M
----
----
Profit attributable to shareholders
42.01%-103.51M
48.78%-524.7M
-178.49M
28.57%-1.02B
-125.71%-1.43B
-98.29%-635.38M
-320.43M
Basic earnings per share
46.84%-0.42
89.79%-2.3
-0.79
38.67%-22.52
-163.60%-36.72
-34.20%-13.93
-10.38
Diluted earnings per share
46.84%-0.42
89.79%-2.3
-0.79
38.67%-22.52
-163.60%-36.72
-34.20%-13.93
-10.38
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Auditor
--
Ernst & Young
--
Ernst & Young
Ernst & Young
Ernst & Young
Ernst & Young
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019
Turnover -41.45%206.42M11.91%634.95M--352.55M841.57%567.39M--60.26M--------
Operating income -41.45%206.42M11.91%634.95M352.55M841.57%567.39M60.26M
Cost of sales 36.00%-17.47M-16.29%-49.09M---27.3M-887.02%-42.22M---4.28M--------
Operating expenses 36.00%-17.47M-16.29%-49.09M-27.3M-887.02%-42.22M-4.28M
Gross profit -41.91%188.95M11.55%585.86M325.25M838.10%525.18M55.98M
Selling expenses 50.18%-110.08M-5.91%-378.81M---220.97M-734.99%-357.66M---42.83M--------
Administrative expenses 44.49%-43.5M-51.98%-217.08M---78.37M5.38%-142.83M-272.47%-150.96M1.37%-40.53M---41.09M
Research and development expenses 43.74%-85.29M-21.27%-425.5M---151.61M5.47%-350.86M-40.61%-371.16M-15.07%-263.97M---229.39M
Revaluation surplus ------------31.17%-657.16M-199.07%-954.74M-23,830.43%-319.23M---1.33M
-Changes in the fair value of other assets ------------31.17%-657.16M-199.07%-954.74M-23,830.43%-319.23M---1.33M
Impairment and provision -1,622.38%-4.77M171.23%837K---277K-803.85%-1.18M---130K--------
-Other impairment is provision -1,622.38%-4.77M171.23%837K---277K-803.85%-1.18M---130K--------
Special items of operating profit 9.77%-54.32M-86.31%-120.01M---60.19M-1,917.47%-64.41M198.66%3.54M89.25%-3.59M---33.41M
Operating profit 41.44%-109.01M47.12%-554.69M-186.16M28.17%-1.05B-132.78%-1.46B-105.53%-627.32M-305.23M
Financing cost -25.23%-5.06M-149.66%-7.77M---4.04M-103.73%-3.11M81.04%-1.53M47.01%-8.06M---15.21M
Earning before tax 40.03%-114.07M46.54%-562.47M-190.2M28.03%-1.05B-130.07%-1.46B-98.29%-635.38M-320.43M
Tax -------55K--------------------
After-tax profit from continuing operations 40.03%-114.07M46.53%-562.52M-190.2M28.03%-1.05B-130.07%-1.46B-98.29%-635.38M-320.43M
Earning after tax 40.03%-114.07M46.53%-562.52M-190.2M28.03%-1.05B-130.07%-1.46B-98.29%-635.38M-320.43M
Minority profit 9.85%-10.57M-36.65%-37.82M---11.72M0.19%-27.68M---27.73M--------
Profit attributable to shareholders 42.01%-103.51M48.78%-524.7M-178.49M28.57%-1.02B-125.71%-1.43B-98.29%-635.38M-320.43M
Basic earnings per share 46.84%-0.4289.79%-2.3-0.7938.67%-22.52-163.60%-36.72-34.20%-13.93-10.38
Diluted earnings per share 46.84%-0.4289.79%-2.3-0.7938.67%-22.52-163.60%-36.72-34.20%-13.93-10.38
Currency Unit CNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified OpinionUnqualified OpinionUnqualified OpinionUnqualified Opinion
Auditor --Ernst & Young--Ernst & YoungErnst & YoungErnst & YoungErnst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data